| scholarly article | Q13442814 |
| P2093 | author name string | M Hirai | |
| M Tsujimoto | |||
| J Vilcek | |||
| C Swenson | |||
| R Feinman | |||
| V J Palombella | |||
| D Henriksen-DeStefano | |||
| P2860 | cites work | An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 |
| Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism | Q24679391 | ||
| Identity of tumour necrosis factor and the macrophage-secreted factor cachectin | Q28286678 | ||
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene | Q29618347 | ||
| Epidermal Growth Factor | Q34192014 | ||
| Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species | Q34237635 | ||
| Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 | ||
| Cyclic AMP: a mitogenic signal for Swiss 3T3 cells | Q35403287 | ||
| Selective reduction of c-myc mRNA in Daudi cells by human beta interferon | Q36255496 | ||
| Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF | Q36291922 | ||
| Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction | Q36349752 | ||
| Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells | Q36350042 | ||
| Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors | Q36405679 | ||
| Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon | Q37347995 | ||
| Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells | Q37554963 | ||
| Type beta transforming growth factor: a bifunctional regulator of cellular growth | Q37672515 | ||
| Cholera toxin stimulates division of 3T3 cells | Q40224853 | ||
| The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. | Q40325756 | ||
| Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin | Q41776641 | ||
| Functional role for c-myc in mitogenic response to platelet-derived growth factor | Q42818115 | ||
| Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells | Q42822892 | ||
| Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells | Q42824886 | ||
| Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells | Q42825965 | ||
| Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin A | Q42826518 | ||
| Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus | Q42937314 | ||
| The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin. | Q53550435 | ||
| Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line | Q69835499 | ||
| Reconstitution of functional receptor for human interleukin-2 in mouse cells | Q69973489 | ||
| Interleukin 1, a potential regulator of fibroblast proliferation | Q70566329 | ||
| Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum | Q70584353 | ||
| In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing | Q70981633 | ||
| Human monocyte stimulation of fibroblast growth by a soluble mediator(s) | Q72084902 | ||
| Characterization of a tyrosine-specific kinase activity in human fibroblast membranes stimulated by platelet-derived growth factor | Q72112527 | ||
| Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity | Q72849923 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 632-643 | |
| P577 | publication date | 1986-03-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors | |
| P478 | volume | 163 |
| Q34661010 | A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor |
| Q36833475 | A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 |
| Q93052453 | A fascinating story of the discovery & development of biologicals for use in clinical medicine |
| Q34623575 | A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity |
| Q67271582 | A monokine which binds to class II histocompatibility proteins |
| Q24297519 | A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 |
| Q68360470 | A physico-chemical comparison of the monocyte-derived fibroblast growth factor and the tumour necrosis factor |
| Q37962343 | A proinflammatory mediator with potential relevance in aging |
| Q41468484 | A protein produced by a monocytic human cell line can induce apoptosis on tumor cells |
| Q69402747 | Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis |
| Q43970143 | Accumulation of an inactive form of p53 protein in cells treated with TNF alpha |
| Q41331926 | Activation of alpha-human tumour necrosis factor (TNF-α) by human monocytes (THP-1) exposed to 2-chloroethyl ethyl sulphide (H-MG) |
| Q42703970 | Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats |
| Q36689099 | Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis |
| Q68825038 | Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia |
| Q26343150 | An inhibitor of thromboxane production attenuates tumor |
| Q35833238 | Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas. |
| Q51699786 | Anesthetic agents induce human mononuclear leucocytes to release cytokines |
| Q33923680 | Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication |
| Q37253521 | Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis |
| Q34375941 | Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor |
| Q37896220 | Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity |
| Q44422722 | Antiviral effects of recombinant tumour necrosis factor in vitro |
| Q42611113 | Asbestos fibres and man made mineral fibres: induction and release of tumour necrosis factor-alpha from rat alveolar macrophages |
| Q35582477 | Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells |
| Q41721765 | Bidirectional interactions between T cells and the extracellular matrix |
| Q41615582 | Biological activity of mutants of human tumour necrosis factor-alpha |
| Q41490927 | Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release |
| Q39527191 | Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses |
| Q34565784 | Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor |
| Q34071308 | Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha |
| Q34648771 | Characterisation of the xenogeneic immune response to microencapsulated fetal pig islet-like cell clusters transplanted into immunocompetent C57BL/6 mice |
| Q69736584 | Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha |
| Q49164180 | Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity |
| Q41747117 | Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor |
| Q55482472 | Combined antitumor effects of TNF and G-CSF on a human medulloblastoma xenograft line. |
| Q47676795 | Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A. |
| Q44354559 | Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha. |
| Q36337258 | Current imaging strategies in rheumatoid arthritis |
| Q47589310 | Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. |
| Q46050002 | Cytotoxicity by tumor necrosis factor is linked with the cell cycle but does not require DNA synthesis |
| Q45191403 | DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-gamma |
| Q40958127 | Defects in signal transduction pathways in chronic B lymphocytic leukemia cells |
| Q34320131 | Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion |
| Q69103907 | Detection of interleukin 1 with human dermal fibroblasts |
| Q68388526 | Dexamethasone inhibits the cytotoxic activity of tumor necrosis factor |
| Q70526828 | Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients |
| Q28317253 | Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures |
| Q42818911 | Dog mastocytoma cells secrete a growth factor for fibroblasts |
| Q41645262 | Double-stranded RNA regulation of DNA synthesis in fibroblasts |
| Q37313256 | Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture |
| Q42465245 | Effect of inflammatory cytokines on human endothelial cell proliferation |
| Q41651824 | Effect of pyridoxine on tumor necrosis factor activitiesin vitro |
| Q36353905 | Effect of tumor necrosis factor alpha on mitogen-activated human B cells |
| Q40994561 | Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo |
| Q41994339 | Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels |
| Q44433473 | Effects of tumor necrosis factor alpha on replication of varicella-zoster virus |
| Q41535923 | Effects of tumor necrosis factor and interferon-beta on proliferation and epidermal growth factor binding in young and senescent WI-38 cells |
| Q40771367 | Elevated temperature regulates tumor necrosis factor-mediated immune killing |
| Q42586072 | Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs |
| Q41435445 | Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts |
| Q33928802 | Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. |
| Q48664415 | Expression of Tumor Necrosis Factor Alpha in the Developing Nervous System |
| Q38203806 | Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. |
| Q92731061 | Extracellular Juxtamembrane Motif Critical for TrkB Preformed Dimer and Activation |
| Q90655869 | Extracellular matrix turnover and inflammation in chemically-induced TMJ arthritis mouse models |
| Q41734640 | Ferric cacodylate efficiently stimulates growth of rat renal glomerular epithelial cells in vitro |
| Q41191845 | Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase |
| Q38571447 | From IFN to TNF: a journey into realms of lore |
| Q41498101 | Functional and morphological effects of tumour necrosis factor alpha in an interleukin 6-producing pulmonary large cell carcinoma with sarcomatoid features |
| Q41315972 | Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. |
| Q33648545 | Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2 |
| Q72863087 | Human MCF activates monocytes to produce IL-1 but not TNF or CSF-1 |
| Q70370045 | Human T cells from autoimmune and normal individuals can produce tumor necrosis factor |
| Q36429520 | Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta) |
| Q40100851 | Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus |
| Q40740841 | Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis |
| Q104064708 | Human skin explant model for the investigation of topical therapeutics |
| Q69363563 | Human tumor necrosis factor increases the resistance against Listeria infection in mice |
| Q35609982 | Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages |
| Q68004797 | Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha |
| Q41667021 | Immobilized IgG Immune Complex Induces Secretion of Tumor Necrosis Factor-α by Porcine Alveolar Macrophages |
| Q35819193 | Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages |
| Q36436866 | Immunologic aspects of pneumoconiosis |
| Q38980032 | Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials |
| Q69368774 | Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease |
| Q36220782 | In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis |
| Q69043503 | In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts |
| Q43414360 | In vitro effect of human recombinant tumor necrosis factor on Entamoeba histolytica trophozoites |
| Q42012319 | In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases |
| Q68183743 | Increase in protein kinase C activity is associated with human fibroblast growth inhibition |
| Q41845609 | Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes |
| Q34635794 | Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor |
| Q37016444 | Induction of tumor necrosis factor by Legionella pneumophila |
| Q34347198 | Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line |
| Q50193577 | Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures |
| Q52252114 | Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor |
| Q41353348 | Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells |
| Q41658623 | Insulin modulation of acute-phase protein production in a human hepatoma cell line |
| Q42809321 | Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro |
| Q41211455 | Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes |
| Q35809793 | Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids |
| Q41217469 | Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB. |
| Q67522842 | Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors |
| Q43445328 | Involvement of leukocyte (β2) integrins (CD18/CD11) in human monocyte tumoricidal activity |
| Q41763455 | Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor |
| Q33989008 | Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts |
| Q68038887 | Kupffer cells from carbon tetrachloride-injured rat livers produce chemotactic factors for fibroblasts and monocytes: the role of tumor necrosis factor-alpha |
| Q41159609 | Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types |
| Q36587774 | Macrophage Production of TGF-? and Regulation by TGF-? |
| Q35811455 | Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells |
| Q40772643 | Mast cell and myofibroblast in wound healing. |
| Q37133226 | Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure |
| Q40927125 | Mast cells as modulators of hair follicle cycling |
| Q39680009 | Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells |
| Q41704905 | Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression |
| Q41156955 | Mechanisms of tubulointerstitial fibrosis |
| Q41739782 | Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins |
| Q39696203 | Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation |
| Q34373393 | Modulation of endogenous hormone action by recombinant human tumor necrosis factor |
| Q40373975 | Modulation of growth and function of human gingival fibroblasts by fibroblast-activating factor derived from Porphyromonas gingivalis W50. |
| Q36949140 | Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection |
| Q30834362 | Molecular cloning, expression and characterization of ovine TNFα |
| Q36315146 | Molecular determinants of biocompatibility |
| Q74258773 | Occupational lung disease |
| Q41490188 | Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor. |
| Q42767981 | Partial characterization of a fibroblast-stimulating factor produced by cloned murine T lymphocytes |
| Q39185300 | Peptide growth factors are multifunctional |
| Q42828902 | Peritoneal lavage fluids stimulate NIH3T3 fibroblast proliferation and contain increased tumour necrosis factor and IL-6 in experimental silica-induced rat peritonitis |
| Q44176124 | Persistent Interleukin-2 Activity and Molecular Evidence for Expression of Lymphotoxin in the Hapten-Immune Model for Pulmonary Interstitial Fibrosis |
| Q40779573 | Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease |
| Q41992698 | Pre-conditioning cryosurgery: Cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system |
| Q52482107 | Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. |
| Q52247210 | Presence of tumour necrosis factor or a related factor in human basophil/mast cells. |
| Q73591580 | Production of inflammatory cytokines by human gingival fibroblasts stimulated by cell-surface preparations of Porphyromonas gingivalis |
| Q35833050 | Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques |
| Q45854429 | Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease |
| Q43819767 | Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha |
| Q44428809 | Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking |
| Q69665966 | Pulmonary inflammation and fibrosis in a murine model of asbestosis and silicosis. Possible role of tumor necrosis factor |
| Q33644008 | Purification and biochemical properties of a human monocyte-derived growth factor |
| Q41335239 | Quantitation of fibroblast population growth rate in situ using computerized image analysis |
| Q77386284 | Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan |
| Q36354082 | Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection |
| Q37803895 | Rationale for immunotherapy of renal cell carcinoma |
| Q43819326 | Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor |
| Q49135297 | Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat x mouse T cell hybrid |
| Q40380705 | Regulation of airway wall remodeling: prospects for the development of novel antiasthma drugs. |
| Q46295962 | Regulation of differentiation of gingival fibroblasts and periodontal ligament cells by rhIL-1 beta and rhTNF-alpha |
| Q41754899 | Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma |
| Q39570233 | Regulation of periodontal ligament cell functions by interleukin-1beta. |
| Q42483974 | Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by antagonists of adipogenesis |
| Q39535151 | Resistance of tumor cells to tumor necrosis factor |
| Q40468550 | Role of T Cells and Cytokines in Effecting Fibrosis |
| Q33567277 | Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies |
| Q23920788 | Role of cytokines and mineral particle profile in the development of coal workers' pneumoconiosis as sssessed by bronchoalveolar lavage |
| Q34248959 | Role of tumor necrosis factor-alpha in wound repair in human vocal fold fibroblasts |
| Q39986878 | Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages |
| Q34557411 | Secretory products of macrophages |
| Q40419646 | Sendai virus induces high levels of tumor necrosis factor mRNA in human peripheral blood leukocytes |
| Q50192260 | Sequential changes in the cell mediators of peritoneal and wound fluids after surgery |
| Q37378024 | Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. |
| Q40806188 | Signaling pathways leading to transcription and translation cooperatively regulate the transient increase in expression of c-Fos protein |
| Q23923190 | Silicosis and coal workers' pneumoconiosis |
| Q35798365 | Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts |
| Q36071867 | Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. |
| Q33585128 | Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin |
| Q72086614 | Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells |
| Q36230900 | Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors |
| Q36354096 | Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide |
| Q68091325 | Stimulation of hepatic T-kininogen production by interferon |
| Q68834400 | Supernatant from an activated human CD4+ T-cell clone modulates the proliferation and collagen synthesis of human dental pulp fibroblasts |
| Q69938747 | Suppression of TNF-stimulated proliferation of diploid fibroblasts and TNF-induced cytotoxicity against transformed fibroblasts by TGF-beta |
| Q80381189 | Survival strategies of Entamoeba histolytica: Modulation of cell-mediated immune responses |
| Q45268324 | Synergy of tumor necrosis factor with protein kinase C activators on T cell activation |
| Q44576441 | Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages |
| Q41079611 | TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite |
| Q34436456 | Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases |
| Q68825052 | Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factor-alpha (cachectin) hy human monocytes |
| Q42550806 | Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages. |
| Q35868040 | The curious incident of the translational dog that didn't bark |
| Q42742648 | The effect of intraoperative lavage with short chain fatty acids (SCFAs) on rectal anastomosis of rats receiving corticosteroids |
| Q34180772 | The genes for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are tandemly arranged on chromosome 17 of the mouse. |
| Q41714428 | The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes |
| Q36436880 | The molecular action of tumor necrosis factor-alpha |
| Q44154203 | The mononuclear cell infiltrate compared with survival in high-grade astrocytomas |
| Q42818138 | The p70 tumor necrosis factor receptor mediates cytotoxicity |
| Q41276467 | The potential biological and clinical significance of the soluble tumor necrosis factor receptors |
| Q36028357 | The production of TNF-alpha and IL-1-like activity by bronchoalveolar leucocytes after intratracheal instillation of crocidolite asbestos |
| Q44778621 | The role of ascorbic acid on collagen structure and levels of serum interleukin-6 and tumour necrosis factor-alpha in experimental lathyrism |
| Q73157877 | The role of interleukin-6 (IL-6) in healing of intestinal anastomoses |
| Q34006160 | The role of the immune system in conjunctival wound healing after glaucoma surgery. |
| Q39572319 | The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response |
| Q35650021 | Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study |
| Q36767429 | Transcriptional regulation of acetyl coenzyme A carboxylase gene expression by tumor necrosis factor in 30A-5 preadipocytes |
| Q34339289 | Transforming growth factor type beta induces monocyte chemotaxis and growth factor production |
| Q55240904 | Tumor Necrosis Factor-p Gene Expression and Its Relationship to the Clinical Features and Histopathogenesis of Peripheral T-Cell Lymphomas |
| Q34295016 | Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat |
| Q33847737 | Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone |
| Q44476688 | Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease |
| Q40388344 | Tumor necrosis factor and human acute leukemia |
| Q41809956 | Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon |
| Q52484542 | Tumor necrosis factor and wound healing. |
| Q35809637 | Tumor necrosis factor expression in human epithelial tumor cell lines |
| Q44647308 | Tumor necrosis factor induced DNA fragmentation of HL-60 cells |
| Q34316477 | Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells. |
| Q34589176 | Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription |
| Q42752122 | Tumor necrosis factor production by human sarcoid alveolar macrophages |
| Q41239746 | Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes |
| Q70392585 | Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats |
| Q67728488 | Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor ? and interleukin 6 |
| Q34333796 | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo |
| Q41556336 | Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells |
| Q71325334 | Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage |
| Q35791667 | Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes |
| Q73231024 | Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human neuroma fibroblasts |
| Q69360037 | Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes |
| Q43518496 | Tumor necrosis factor-alpha induces mRNA for collagenase and TIMP in human skin fibroblasts |
| Q70936149 | Tumor necrosis factor-alpha inhibits collagen synthesis in human and rat granulation tissue fibroblasts |
| Q41605194 | Tumor necrosis factor-alpha stimulates colony formation by a megakaryoblastic leukemia cell line, CMK |
| Q41528513 | Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts |
| Q45269757 | Tumor necrosis factor-induced protein phosphorylation in human neutrophils |
| Q36357510 | Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor |
| Q39773065 | Tumor necrosis factor: recent advances |
| Q42737018 | Tumour necrosis factor |
| Q40644530 | Tumour necrosis factor and associated cytokines in the host's response to malaria |
| Q69917734 | Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies |
| Q67552952 | Tumour necrosis factor enhances the asbestos-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes (PMN) |
| Q36029538 | Tumour necrosis factor in man: clinical and biological observations |
| Q33562931 | Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis |
| Q41203399 | Tumour necrosis factor in synovial exudates |
| Q42087829 | Tumour necrosis factor, cholestatic jaundice, and chronic liver disease |
| Q41205458 | Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective |
| Q41470229 | Tumour necrosis factor-alpha upregulates transferrin receptors in K 562 cells |
| Q68688192 | Tumour necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers |
| Q37916679 | Tumour necrosis factor: a cytokine with multiple biological activities |
| Q35215327 | Understanding the final stages of wound contraction |
| Q70885044 | Use of a pericardial fat pad flap for preventing bronchopleural fistula: an experimental study focusing on the angiogenesis and cytokine production of the fat pad |
Search more.